Citations (76)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Michael D. Schultz, John J. Suschak, Davide Botta, Aaron Silva-Sanchez, R. Glenn King, Thomas W. Detchemendy, Chetan D. Meshram, Jeremy B. Foote, Fen Zhou, Jennifer L. Tipper, Jianfeng Zhang, Kevin S. Harrod, Sixto M. Leal$suffix/text()$suffix/text(), Troy D. Randall, M. Scot Roberts, Bertrand Georges & Frances E. Lund. (2022) A single intranasal administration of AdCOVID protects against SARS-CoV-2 infection in the upper and lower respiratory tracts. Human Vaccines & Immunotherapeutics 18:6.
Read now
Read now
Juan Manuel Figueroa, Mónica Edith Lombardo, Ariel Dogliotti, Luis Pedro Flynn, Robert Giugliano, Guido Simonelli, Ricardo Valentini, Agñel Ramos, Pablo Romano, Marcelo Marcote, Alicia Michelini, Alejandro Salvado, Emilio Sykora, Cecilia Kniz, Marcelo Kobelinsky, David Manuel Salzberg, Diana Jerusalinsky & Osvaldo Uchitel. (2021) Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Postexposure Prophylaxis of COVID-19 in Hospital Personnel Dedicated to Patients Care with COVID-19 Disease. International Journal of General Medicine 14, pages 6277-6286.
Read now
Read now
Franck J. D. Mennechet, Océane Paris, Aline Raissa Ouoba, Sofia Salazar Arenas, Sodiomon B. Sirima, Guy R. Takoudjou Dzomo, Amidou Diarra, Isidore T Traore, Dramane Kania, Karsten Eichholz, Eric A. Weaver, Edouard Tuaillon & Eric J. Kremer. (2019) A review of 65 years of human adenovirus seroprevalence. Expert Review of Vaccines 18:6, pages 597-613.
Read now
Read now
Articles from other publishers (73)
Sujhey Hernández-Bazán, Dulce Mata-Espinosa, Octavio Ramos-Espinosa, Vasti Lozano-Ordaz, Jorge Barrios-Payán, Fernando López-Casillas & Rogelio Hernández-Pando. (2023) Adenoviral Vector Codifying for TNF as a Co-Adjuvant Therapy against Multi-Drug-Resistant Tuberculosis. Microorganisms 11:12, pages 2934.
Crossref
Crossref
Jiaqi Zhang, Jiangyong Zeng, Zhenjie Yuan, Xiangyue Huang, Jinbo Wu, Qisheng Yu, Taoyun Chen, Gunan Den, Chenxi Zhu & Bin Zhang. (2023) Immunogenicity and protective efficacy of a recombinant adenovirus containing the fusion protein of bovine parainfluenza virus type 3 genotype C in mice. Microbial Pathogenesis 185, pages 106444.
Crossref
Crossref
Krithiga Natesan, Shrikrishna Isloor, Balamurugan Vinayagamurthy, Sharada Ramakrishnaiah, Rathnamma Doddamane & Anthony R. Fooks. (2023) Developments in Rabies Vaccines: The Path Traversed from Pasteur to the Modern Era of Immunization. Vaccines 11:4, pages 756.
Crossref
Crossref
Anum Syyam, Amjad Nawaz, Aroosa Ijaz, Umar Sajjad, Anila Fazil, Sofia Irfan, Aleeha Muzaffar, Muhammad Shahid, Muhammad Idrees, Kausar Malik & Samia Afzal. (2022) Adenovirus vector system: construction, history and therapeutic applications. BioTechniques 73:6, pages 297-305.
Crossref
Crossref
Yuchen Wang, Lin Ling, Zilei Zhang & Alejandro Marin-Lopez. (2022) Current Advances in Zika Vaccine Development. Vaccines 10:11, pages 1816.
Crossref
Crossref
Océane Paris, Franck J. D. Mennechet & E. J. Kremer. (2022) Human innate lymphoid cell activation by adenoviruses is modified by host defense proteins and neutralizing antibodies. Frontiers in Immunology 13.
Crossref
Crossref
Sujhey Hernández-Bazán, Dulce Mata-Espinosa, Vasti Lozano-Ordaz, Octavio Ramos-Espinosa, Jorge Barrios-Payán, Fernando López-CasillasRogelio Hernández Pando. (2022) Immune Regulatory Effect of Osteopontin Gene Therapy in a Murine Model of Multidrug Resistant Pulmonary Tuberculosis. Human Gene Therapy 33:19-20, pages 1037-1051.
Crossref
Crossref
Haisu Yi, Qian Wang, Jiankai Deng, Hengchun Li, Yingkun Zhang, Zhilong Chen, Tianxin Ji, Wenming Liu, Xuehua Zheng, Qinghua Ma, Xinxin Sun, Yudi Zhang, Xuegao Yu, Mengzhang He, Ling Chen & Ying Feng. (2022) Seroprevalence of neutralizing antibodies against adenovirus type 26 and 35 in healthy populations from Guangdong and Shandong provinces, China. Virologica Sinica 37:5, pages 716-723.
Crossref
Crossref
Yiquan Li, Chao Shang, Zirui Liu, Jicheng Han, Wenjie Li, Pengpeng Xiao, Nan Li, Shanzhi Li, Zhiru Xiu, Gaojie Song, Yaru Li, Ningyi Jin, Jinbo Fang, Xiao Li & Yilong Zhu. (2022) Apoptin mediates mitophagy and endogenous apoptosis by regulating the level of ROS in hepatocellular carcinoma. Cell Communication and Signaling 20:1.
Crossref
Crossref
Scott Bachus, Nikolas Akkerman, Lauren Fulham, Drayson Graves, Caelan Stephanson, Harram Memon, Matthew S. Miller & Peter Pelka. (2022) Adenovirus 5 Vectors Expressing SARS-CoV-2 Proteins. mSphere 7:2.
Crossref
Crossref
Luca Soraci, Fabrizia Lattanzio, Giulia Soraci, Maria Elsa Gambuzza, Claudio Pulvirenti, Annalisa Cozza, Andrea Corsonello, Filippo Luciani & Giovanni Rezza. (2022) COVID-19 Vaccines: Current and Future Perspectives. Vaccines 10:4, pages 608.
Crossref
Crossref
Simone Pecetta, Sven Kratochvil, Yu Kato, Kumaran Vadivelu & Rino Rappuoli. (2022) Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines. Pharmacological Reviews 74:1, pages 313-339.
Crossref
Crossref
Hyung Suk Oh, Fernando M. Diaz, Changhong Zhou, Nicholas Carpenter & David M. Knipe. (2022) CRISPR-Cas9 expressed in stably transduced cell lines promotes recombination and selects for herpes simplex virus recombinants. Current Research in Virological Science 3, pages 100023.
Crossref
Crossref
G. Antonarelli, C. Corti, P. Tarantino, L. Ascione, J. Cortes, P. Romero, E.A. Mittendorf, M.L. Disis & G. Curigliano. (2021) Therapeutic cancer vaccines revamping: technology advancements and pitfalls. Annals of Oncology 32:12, pages 1537-1551.
Crossref
Crossref
Wei Zhao, Peng Zhang, Shuang Bai, Min Lv, Jian Wang, Weixin Chen, Qingzhong Yu & Jiang Wu. (2021) Heterologous prime-boost regimens with HAdV-5 and NDV vectors elicit stronger immune responses to Ebola virus than homologous regimens in mice. Archives of Virology 166:12, pages 3333-3341.
Crossref
Crossref
Kiana Shahzamani, Fatemeh Mahmoudian, Shahrzad Ahangarzadeh, Mohammad Mehdi Ranjbar, Leila Beikmohammadi, Samira Bahrami, Elmira Mohammadi, Sahar Esfandyari, Abbas Alibakhshi & Shaghayegh Haghjooy Javanmard. (2021) Vaccine design and delivery approaches for COVID-19. International Immunopharmacology 100, pages 108086.
Crossref
Crossref
Yingchen Wang, Zhe Zhang, Lei Shang, Hong Gao, Xiqiao Du, Falong Li, Ya Gao, Guiyun Qi, Weiyuan Guo, Zhangyi Qu & Tuo Dong. (2021) Immunological Study of Reconstructed Common Ancestral Sequence of Adenovirus Hexon Protein. Frontiers in Microbiology 12.
Crossref
Crossref
Yan-Feng Yao, Ze-Jun Wang, Ren-Di Jiang, Xue Hu, Hua-Jun Zhang, Yi-Wu Zhou, Ge Gao, Ying Chen, Yun Peng, Mei-Qin Liu, Ya-Nan Zhang, Juan Min, Jia Lu, Xiao-Xiao Gao, Jing Guo, Cheng Peng, Xu-Rui Shen, Qian Li, Kai Zhao, Lian Yang, Xin Wan, Bo Zhang, Wen-Hui Wang, Jia Wu, Peng Zhou, Xing-Lou Yang, Shuo Shen, Chao Shan, Zhi-Ming Yuan & Zheng-Li Shi. (2021) Protective Efficacy of Inactivated Vaccine against SARS-CoV-2 Infection in Mice and Non-Human Primates. Virologica Sinica 36:5, pages 879-889.
Crossref
Crossref
Kehui Zhou, Chaoqun Li, Wen Shi, Xiaodan Hu, Kutty Selva Nandakumar, Shibo Jiang & Naru Zhang. (2021) Current Progress in the Development of Zika Virus Vaccines. Vaccines 9:9, pages 1004.
Crossref
Crossref
R. Glenn King, Aaron Silva-Sanchez, Jessica N. Peel, Davide Botta, Alexandria M. Dickson, Amelia K. Pinto, Selene Meza-Perez, S. Rameeza Allie, Michael D. Schultz, Mingyong Liu, John E. Bradley, Shihong Qiu, Guang Yang, Fen Zhou, Esther Zumaquero, Thomas S. Simpler, Betty Mousseau, John T. KillianJr.Jr., Brittany Dean, Qiao Shang, Jennifer L. Tipper, Christopher A. Risley, Kevin S. Harrod, Tsungwei Feng, Young Lee, Bethlehem Shiberu, Vyjayanthi Krishnan, Isabelle Peguillet, Jianfeng Zhang, Todd J. Green, Troy D. Randall, John J. Suschak, Bertrand Georges, James D. Brien, Frances E. Lund & M. Scot Roberts. (2021) Single-Dose Intranasal Administration of AdCOVID Elicits Systemic and Mucosal Immunity against SARS-CoV-2 and Fully Protects Mice from Lethal Challenge. Vaccines 9:8, pages 881.
Crossref
Crossref
Hyun Mi Kang, Eun Hwa Choi & Yae-Jean Kim. (2021) Updates on the coronavirus disease 2019 vaccine and consideration in children. Clinical and Experimental Pediatrics 64:7, pages 328-338.
Crossref
Crossref
Satoru Shinkuma. (2021) Advances in gene therapy and their application to skin diseases: A review. Journal of Dermatological Science 103:1, pages 2-9.
Crossref
Crossref
Coralie F. Daussy, Noémie Pied & Harald Wodrich. (2021) Understanding Post Entry Sorting of Adenovirus Capsids; A Chance to Change Vaccine Vector Properties. Viruses 13:7, pages 1221.
Crossref
Crossref
Hye-Hyun Ahn, Christine Carrington, Yizong Hu, Heng-wen Liu, Christy Ng, Hwanhee Nam, Andrew Park, Catherine Stace, Will West, Hai-Quan Mao, Martin G. Pomper, Christopher G. Ullman & Il Minn. (2021) Nanoparticle-mediated tumor cell expression of mIL-12 via systemic gene delivery treats syngeneic models of murine lung cancers. Scientific Reports 11:1.
Crossref
Crossref
Qian He, Qunying Mao, Jialu Zhang, Lianlian Bian, Fan Gao, Junzhi Wang, Miao Xu & Zhenglun Liang. (2021) COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations. Frontiers in Immunology 12.
Crossref
Crossref
Kotou Sangare, Iskra Tuero, Mohammad Arif Rahman, Tanya Hoang, Leia K. Miller-Novak, Diego A. Vargas-Inchaustegui, David J. Venzon, Celia LaBranche, David C. Montefiori, Marjorie Robert-Guroff & Michael A. Thomas. (2021) The Immunological Impact of Adenovirus Early Genes on Vaccine-Induced Responses in Mice and Nonhuman Primates. Journal of Virology 95:7.
Crossref
Crossref
Raquel L. RussellPeter PelkaBrian L. Mark. (2021) Frontrunners in the race to develop a SARS-CoV-2 vaccine. Canadian Journal of Microbiology 67:3, pages 189-212.
Crossref
Crossref
Vrishali S. Salian, Jessica A. Wright, Peter T. Vedell, Sanjana Nair, Chenxu Li, Mahathi Kandimalla, Xiaojia Tang, Eva M. Carmona Porquera, Krishna R. Kalari & Karunya K. Kandimalla. (2021) COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies. Molecular Pharmaceutics 18:3, pages 754-771.
Crossref
Crossref
Jote T. Bulcha, Yi Wang, Hong Ma, Phillip W. L. Tai & Guangping Gao. (2021) Viral vector platforms within the gene therapy landscape. Signal Transduction and Targeted Therapy 6:1.
Crossref
Crossref
Denis Y Logunov, Inna V Dolzhikova, Dmitry V Shcheblyakov, Amir I Tukhvatulin, Olga V Zubkova, Alina S Dzharullaeva, Anna V Kovyrshina, Nadezhda L Lubenets, Daria M Grousova, Alina S Erokhova, Andrei G Botikov, Fatima M Izhaeva, Olga Popova, Tatiana A Ozharovskaya, Ilias B Esmagambetov, Irina A Favorskaya, Denis I Zrelkin, Daria V Voronina, Dmitry N Shcherbinin, Alexander S Semikhin, Yana V Simakova, Elizaveta A Tokarskaya, Daria A Egorova, Maksim M Shmarov, Natalia A Nikitenko, Vladimir A Gushchin, Elena A Smolyarchuk, Sergey K Zyryanov, Sergei V Borisevich, Boris S Naroditsky & Alexander L Gintsburg. (2021) Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. The Lancet 397:10275, pages 671-681.
Crossref
Crossref
Jin-Hong Yoo. (2021) What We Do Know and Do Not Yet Know about COVID-19 Vaccines as of the Beginning of the Year 2021. Journal of Korean Medical Science 36:6.
Crossref
Crossref
O.M. Drapkina, L.N. Ryzhakova, V.N. Shishkova, I.A. Skripnikova, S.A. Burns, A.Yu. Gorshkov, O.A. Litinskaya, K.E. Imamgayazova, I.M. Lobachev & A.V. Veretennikova. (2021) First real-world experience of Gam-COVID-Vac Sputnik V vaccine use. Profilakticheskaya meditsina 24:10, pages 53.
Crossref
Crossref
Hyun Mi Kang, Eun Hwa Choi & Yae-Jean Kim. (2021) Updates on Coronavirus Disease-2019 Vaccine and Consideration in Children. Pediatric Infection & Vaccine 28:1, pages 7.
Crossref
Crossref
Jiatong Su. (2021) The Techniques Used on the Development of COVID-19 Vaccine. E3S Web of Conferences 271, pages 01037.
Crossref
Crossref
Nicholas W. Lukacs & Carrie-Anne Malinczak. (2020) Harnessing Cellular Immunity for Vaccination against Respiratory Viruses. Vaccines 8:4, pages 783.
Crossref
Crossref
Sandra S. Ring, Michał Królik, Fabienne Hartmann, Erika Schmidt, Omar Hasan Ali, Burkhard Ludewig, Stefan Kochanek & Lukas Flatz. (2020) Heterologous Prime Boost Vaccination Induces Protective Melanoma-Specific CD8+ T Cell Responses. Molecular Therapy - Oncolytics 19, pages 179-187.
Crossref
Crossref
Aditi Kumar, Mohammed Nabil Quraishi, Jonathan P Segal, Tim Raine & Matthew J Brookes. (2020) COVID-19 vaccinations in patients with inflammatory bowel disease. The Lancet Gastroenterology & Hepatology 5:11, pages 965-966.
Crossref
Crossref
Saman Zafar, Muhammad Sohail Arshad, Sameen Fatima, Amna Ali, Aliyah Zaman, Elshaimaa Sayed, Ming-Wei Chang & Zeeshan Ahmad. (2020) COVID-19: Current Developments and Further Opportunities in Drug Delivery and Therapeutics. Pharmaceutics 12:10, pages 945.
Crossref
Crossref
Wenli Zhang, Kemal Mese, Sebastian Schellhorn, Nora Bahlmann, Nicolas Mach, Oskar Bunz, Akshay Dhingra, Elias Hage, Marie-Edith Lafon, Harald Wodrich, Albert Heim & Anja Ehrhardt. (2020) High-Throughput Cloning and Characterization of Emerging Adenovirus Types 70, 73, 74, and 75. International Journal of Molecular Sciences 21:17, pages 6370.
Crossref
Crossref
Denis Y Logunov, Inna V Dolzhikova, Olga V Zubkova, Amir I Tukhvatulin, Dmitry V Shcheblyakov, Alina S Dzharullaeva, Daria M Grousova, Alina S Erokhova, Anna V Kovyrshina, Andrei G Botikov, Fatima M Izhaeva, Olga Popova, Tatiana A Ozharovskaya, Ilias B Esmagambetov, Irina A Favorskaya, Denis I Zrelkin, Daria V Voronina, Dmitry N Shcherbinin, Alexander S Semikhin, Yana V Simakova, Elizaveta A Tokarskaya, Nadezhda L Lubenets, Daria A Egorova, Maksim M Shmarov, Natalia A Nikitenko, Lola F Morozova, Elena A Smolyarchuk, Evgeny V Kryukov, Vladimir F Babira, Sergei V Borisevich, Boris S Naroditsky & Alexander L Gintsburg. (2020) Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia. The Lancet 396:10255, pages 887-897.
Crossref
Crossref
Guy-Alain Junter & Laurent Lebrun. (2020) Polysaccharide-based chromatographic adsorbents for virus purification and viral clearance. Journal of Pharmaceutical Analysis 10:4, pages 291-312.
Crossref
Crossref
Hui Wang, Yuntao Zhang, Baoying Huang, Wei Deng, Yaru Quan, Wenling Wang, Wenbo Xu, Yuxiu Zhao, Na Li, Jin Zhang, Hongyang Liang, Linlin Bao, Yanfeng Xu, Ling Ding, Weimin Zhou, Hong Gao, Jiangning Liu, Peihua Niu, Li Zhao, Wei Zhen, Hui Fu, Shouzhi Yu, Zhengli Zhang, Guangxue Xu, Changgui Li, Zhiyong Lou, Miao Xu, Chuan Qin, Guizhen Wu, George Fu Gao, Wenjie Tan & Xiaoming Yang. (2020) Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2. Cell 182:3, pages 713-721.e9.
Crossref
Crossref
Yiquan Li, Yilong Zhu, Jinbo Fang, Wenjie Li, Shanzhi Li, Xing Liu, Zirui Liu, Gaojie Song, Chao Shang, Jianan Cong, Bing Bai, Lili Sun, Ningyi Jin & Xiao Li. (2020) Apoptin Regulates Apoptosis and Autophagy by Modulating Reactive Oxygen Species (ROS) Levels in Human Liver Cancer Cells. Frontiers in Oncology 10.
Crossref
Crossref
Vipul K. Singh, Abhishek Mishra, Shubhra Singh, Premranjan Kumar, Manisha Singh, Chinnaswamy Jagannath & Arshad Khan. (2020) Emerging Prevention and Treatment Strategies to Control COVID-19. Pathogens 9:6, pages 501.
Crossref
Crossref
Mariangela Garofalo, Monika Staniszewska, Stefano Salmaso, Paolo Caliceti, Katarzyna Wanda Pancer, Magdalena Wieczorek & Lukasz Kuryk. (2020) Prospects of Replication-Deficient Adenovirus Based Vaccine Development against SARS-CoV-2. Vaccines 8:2, pages 293.
Crossref
Crossref
Zachary R. Stromberg, Will Fischer, Steven B. Bradfute, Jessica Z. Kubicek-Sutherland & Peter Hraber. (2020) Vaccine Advances against Venezuelan, Eastern, and Western Equine Encephalitis Viruses. Vaccines 8:2, pages 273.
Crossref
Crossref
Kayhan Ozkan. (2020) How Close are We to a COVID-19 Vaccine?. Journal of Pure and Applied Microbiology 14:suppl 1, pages 893-902.
Crossref
Crossref
Koos Korsten & Louis J Bont. (2020) Sustained Cellular and Humoral Immune Responses From an Adenoviral Vector-based Respiratory Syncytial Virus Vaccine. Clinical Infectious Diseases 70:10, pages 2082-2083.
Crossref
Crossref
John Benest, Sophie Rhodes, Sara Afrough, Thomas Evans & Richard White. (2020) Response Type and Host Species may be Sufficient to Predict Dose-Response Curve Shape for Adenoviral Vector Vaccines. Vaccines 8:2, pages 155.
Crossref
Crossref
E. S. Sedova, L. V. Verkhovskaya, E. A. Artemova, D. N. Shcherbinin, A. A. Lysenko, I. A. Rudneva, A. V. Lyashko, S. A. Alekseeva, I. B. Esmagambetov, T. A. Timofeeva & M. M. Shmarov. (2020) Protecting Mice from H7 Avian Influenza Virus by Immunisation with a Recombinant Adenovirus Encoding Influenza A Virus Conserved Antigens. BIOpreparations. Prevention, Diagnosis, Treatment 20:1, pages 60-67.
Crossref
Crossref
Sara Afrough, Sophie Rhodes, Thomas Evans, Richard White & John Benest. (2020) Immunologic Dose-Response to Adenovirus-Vectored Vaccines in Animals and Humans: A Systematic Review of Dose-Response Studies of Replication Incompetent Adenoviral Vaccine Vectors when Given via an Intramuscular or Subcutaneous Route. Vaccines 8:1, pages 131.
Crossref
Crossref
Sumit Ghosh, Alex M. Brown, Chris Jenkins & Katie Campbell. (2020) Viral Vector Systems for Gene Therapy: A Comprehensive Literature Review of Progress and Biosafety Challenges. Applied Biosafety 25:1, pages 7-18.
Crossref
Crossref
Ashish Tiwari, Ablesh Gautam, Sudipta Bhat & Yashpal Singh Malik. 2020. Genomics and Biotechnological Advances in Veterinary, Poultry, and Fisheries. Genomics and Biotechnological Advances in Veterinary, Poultry, and Fisheries
361
380
.
Rafael Kroon Campos, Lorena Preciado-Llanes, Sasha R. Azar, Cesar Lopez-Camacho, Arturo Reyes-Sandoval & Shannan L. Rossi. (2019) A Single and Un-Adjuvanted Dose of a Chimpanzee Adenovirus-Vectored Vaccine against Chikungunya Virus Fully Protects Mice from Lethal Disease. Pathogens 8:4, pages 231.
Crossref
Crossref
Kamran Haq, Yimei Jia, S. Mehdy Elahi, Susanne MacLean, Bassel Akache, Komal Gurnani, Anindita Chattopadhyay, Nazila Nazemi-Moghaddam, Rénald Gilbert, Michael J. McCluskie & Risini D. Weeratna. (2019) Evaluation of recombinant adenovirus vectors and adjuvanted protein as a heterologous prime-boost strategy using HER2 as a model antigen. Vaccine 37:47, pages 7029-7040.
Crossref
Crossref
Eric A. Weaver. (2019) Dose Effects of Recombinant Adenovirus Immunization in Rodents. Vaccines 7:4, pages 144.
Crossref
Crossref
Xiang Wang, Zihao Fang, Jun Xiong, Kaiyan Yang, Yudan Chi, Xinying Tang, Li Ma, Renhuai Zhang, Fei Deng, Ke Lan & Dongming Zhou. (2019) A chimpanzee adenoviral vector-based rabies vaccine protects beagle dogs from lethal rabies virus challenge. Virology 536, pages 32-38.
Crossref
Crossref
Brennetta J. Crenshaw, Leandra B. Jones, Courtnee’ R. Bell, Sanjay Kumar & Qiana L. Matthews. (2019) Perspective on Adenoviruses: Epidemiology, Pathogenicity, and Gene Therapy. Biomedicines 7:3, pages 61.
Crossref
Crossref
Yanting Chen, Zhengzheng Wu, Xiaolei Zhu, Meijuan Zhang, Xuefeng Zang, Xiaoxi Li & Yun Xu. (2019) OCT4B-190 protects against ischemic stroke by modulating GSK-3β/HDAC6. Experimental Neurology 316, pages 52-62.
Crossref
Crossref
Patricia A. Darrah, Robert M. DiFazio, Pauline Maiello, Hannah P. Gideon, Amy J. Myers, Mark A. Rodgers, Joshua A. Hackney, Thomas Lindenstrom, Thomas Evans, Charles A. Scanga, Victor Prikhodko, Peter Andersen, Philana Ling Lin, Dominick Laddy, Mario Roederer, Robert A. Seder & JoAnne L. Flynn. (2019) Boosting BCG with proteins or rAd5 does not enhance protection against tuberculosis in rhesus macaques. npj Vaccines 4:1.
Crossref
Crossref
Anja Scholzen, Guilhem Richard, Leonard Moise, Laurie A. Baeten, Patrick M. Reeves, William D. Martin, Timothy A. Brauns, Christine M. Boyle, Susan Raju Paul, Richard Bucala, Richard A. Bowen, Anja Garritsen, Anne S. De Groot, Ann E. Sluder & Mark C. Poznansky. (2019) Promiscuous Coxiella burnetii CD4 Epitope Clusters Associated With Human Recall Responses Are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever Vaccine. Frontiers in Immunology 10.
Crossref
Crossref
Davor Nestić, Taco G. Uil, Jiangtao Ma, Soumitra Roy, Jort Vellinga, Andrew H. Baker, Jerome Custers & Dragomira Majhen. (2019) αvβ3 Integrin Is Required for Efficient Infection of Epithelial Cells with Human Adenovirus Type 26. Journal of Virology 93:1.
Crossref
Crossref
Wing-Fu Lai. 2019. Delivery of Therapeutics for Biogerontological Interventions. Delivery of Therapeutics for Biogerontological Interventions
25
36
.
Brianna L. Bullard, Brigette N. Corder, Matthew J. Gorman, Michael S. Diamond & Eric A. Weaver. (2018) Efficacy of a T Cell-Biased Adenovirus Vector as a Zika Virus Vaccine. Scientific Reports 8:1.
Crossref
Crossref
Ekramy E. Sayedahmed, Rashmi Kumari, Shruti Shukla, Ahmed O. Hassan, Sulma I. Mohammed, Ian A. York, Shivaprakash Gangappa, Suryaprakash Sambhara & Suresh K. Mittal. (2018) Longevity of adenovirus vector immunity in mice and its implications for vaccine efficacy. Vaccine 36:45, pages 6744-6751.
Crossref
Crossref
Rebecca K. Carrell, Rebecca A. Stanton, Stephen P. Ethier, Amanda C. LaRue & Adam C. Soloff. (2018) ICOSL-augmented adenoviral-based vaccination induces a bipolar Th17/Th1 T cell response against unglycosylated MUC1 antigen. Vaccine 36:42, pages 6262-6269.
Crossref
Crossref
Guo-Zhen Lin, Ju-Tian Yang, Suo-Cheng Wei, Shi-En Chen, Sheng-Dong Huo & Zhong-Ren Ma. (2018) Immunogenicity of adenovirus and DNA vaccines co-expressing P39 and lumazine synthase proteins of Brucella abortus in BALB/c mice. Tropical Animal Health and Production 50:5, pages 957-963.
Crossref
Crossref
Gaiyun Li, Yuanfei Zhu, Dianhui Shao, Hao Chang, Xiaoming Zhang, Dongming Zhou, Yueqiu Gao, Ke Lan & Qiang Deng. (2017) Recombinant covalently closed circular DNA of hepatitis B virus induces long‐term viral persistence with chronic hepatitis in a mouse model. Hepatology 67:1, pages 56-70.
Crossref
Crossref
Malin Källsten, Arina Gromova, Hongxing Zhao, Alberto Valdés, Anne Konzer, Ulf Pettersson & Sara Bergström Lind. (2017) Temporal characterization of the non-structural Adenovirus type 2 proteome and phosphoproteome using high-resolving mass spectrometry. Virology 511, pages 240-248.
Crossref
Crossref
Ben A. Bailey-Elkin, Robert C.M. Knaap, Marjolein Kikkert & Brian L. Mark. (2017) Structure and Function of Viral Deubiquitinating Enzymes. Journal of Molecular Biology 429:22, pages 3441-3470.
Crossref
Crossref
Yue-Ying Jiao, Yuan-Hui Fu, Yi-Fei Yan, Ying Hua, Yao Ma, Xiu-Juan Zhang, Jing-Dong Song, Xiang-Lei Peng, Jiaqiang Huang, Tao Hong & Jin-Sheng He. (2017) A single intranasal administration of virus-like particle vaccine induces an efficient protection for mice against human respiratory syncytial virus. Antiviral Research 144, pages 57-69.
Crossref
Crossref
Babita Agrawal, Shakti Singh, Nancy Gupta, Wen Li, Satish Vedi & Rakesh Kumar. (2017) Unsolved Puzzles Surrounding HCV Immunity: Heterologous Immunity Adds Another Dimension. International Journal of Molecular Sciences 18:8, pages 1626.
Crossref
Crossref
Hyungsuk Oh, Fernando M. Diaz, Changhong Zhou, Nicholas Carpenter & David Knipe. (2022) CRISPR-Cas9 Expressed in Stably Transduced Cell Lines Promotes Recombination and Selects for Herpes Simplex Virus Recombinants between Co-Transfected DNAs. SSRN Electronic Journal.
Crossref
Crossref